Immobilie kaufen in North Carolina, USA

The company is currently appealing the delisting decision to the NYSE American Listings Qualifications Panel, with trading suspended during the appeal process. The reverse split was implemented by the Board of Directors as part of efforts to regain NYSE American listing compliance. The company expects near-term revenues from its recently announced Know Labs Technology Licensing initiative while continuing its focus on blood glucose monitoring development. Know Labs (KNWN) has announced the cancellation of its Special Meeting of Stockholders that was scheduled for March 7, 2025. This cancellation follows the company’s recent implementation of a 1-for-40 reverse stock split of its authorized and outstanding common stock on February 18, 2025, which became effective February 19, 2025.

• Know Labs (KNWN) has announced the cancellation of its Special Meeting of Stockholders that was scheduled for March 7, 2025.
• You can send this report to our support team via email when reporting website issues.
• An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Know Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Know Labs Inc (KNW) pioneers non-invasive diagnostic technologies using its patented Bio-RFID and ChromaID systems, transforming traditional medical testing methods. This page serves as the definitive source for verified updates on the company’s regulatory progress, clinical validations, and strategic partnerships in the healthtech sector. A major component of the strategy is the use of Bitcoin BTC/USD as a treasury asset, giving Know Labs significant exposure to digital assets. Management will use a multiple of net asset value metric to evaluate market valuation against Bitcoin holdings, which are expected to make up 82% of the company’s market cap, assuming BTC is priced at $105,000. The Barchart Technical Opinion widget shows you today’s overall Barchart Opinion with general information on how to interpret the short and longer term signals. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods.

MarketBeat All Access Features

Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. For example, a price above its moving average is generally considered an upward trend or a buy.

• The System Report captures technical information about the current page to help our support team troubleshoot any issues you may be experiencing.
• You can send this report to our support team via email when reporting website issues.
• An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
• Access real-time announcements about wearable device developments, FDA submissions, and peer-reviewed study results.
• Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment.
• For example, a price above its moving average is generally considered an upward trend or a buy.

Fundamentals

An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment. Know Labs’ top institutional shareholders include Cerity Partners LLC (1.07%), Corient Private Wealth LLC (0.67%) and United Capital Management of KS Inc. (0.33%). Insiders that own company stock include William Arthur Owens, Ronald P Erickson, Ichiro John Paul Takesako, knw mlsmatrix Leonardo Mouta Trautwein and Jessica English.

All materials adhere to journalistic standards for accuracy, providing actionable insights without speculative commentary. Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment. Please log in to your account or sign up in order to add this asset to your watchlist. Enter your email address and we’ll send you MarketBeat’s list of seven best retirement stocks and why they should be in your portfolio.

KNW Stock News Headlines

Headquartered in the United States, Know Labs is positioning its Bio‐RFID platform for global deployment, with initial emphasis on markets that demand painless, continuous biomarker tracking. The management team brings together expertise in biomedical engineering, product development and medical‐device commercialization. As the company advances toward regulatory clearance and potential strategic partnerships, it aims to license its technology to device manufacturers or offer integrated solutions directly to end users.

The System Report captures technical information about the current page to help our support team troubleshoot any issues you may be experiencing. You can send this report to our support team via email when reporting website issues. Greg Kidd has been appointed as CEO and Chairman, introducing a new vision centered on the USBC token – a U.S.-dollar denominated, blockchain-based token offering high-yield rewards. The leadership transition includes Linda Jenkinson as Vice Chair, Kirk Chapman as COO, and Kitty Payne as CFO. Know Labs founder Ron Erickson will serve as President of a new division focused on diagnostic research and as Lead Director. Key content includes earnings call summaries, technology licensing agreements, and analysis of clinical trial outcomes.

Know Labs (KNWN) has announced a 1-for-40 reverse stock split of its common stock, effective February 19, 2025. The company’s stock will temporarily trade under ‘KNWND’ for 20 days before reverting to ‘KNWN’ on the OTC Pink Market. This move follows the company’s delisting from NYSE American due to bid prices falling below $0.10. Shares of Know Labs reverse split on Tuesday, February 18th 2025.The 1-40 reverse split was announced on Tuesday, February 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 19th 2025.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways. Know Labs has assembled a patent portfolio covering hardware design, signal analysis and data‐interpretation methods, and is collaborating with academic and industry partners to refine its technology. These collaborations are intended to demonstrate the accuracy, reliability and safety of non‐invasive measurements across applications in diabetes management, sports performance, consumer wellness and beyond.

Know Labs (KNWN) reported Q1 FY2025 financial results, showing a net loss of $4.67 million, up 35.4% from $3.45 million in Q1 FY2024. The company recorded a non-cash charge of $2.45 million related to stock-based compensation, debt extinguishment, warrant repricing, and debt issuance costs. Know Labs Inc KNW shares soared Friday afternoon after the company announced in a press release that it will be acquired by Goldeneye 1995 LLC, an entity led by fintech investor and former Ripple Chief Risk Officer Greg Kidd. The company plans to engage with potential strategic partners and industry leaders in diabetes management to explore collaboration opportunities. Access real-time announcements about wearable device developments, FDA submissions, and peer-reviewed study results. Investors and healthcare professionals will find curated updates on product commercialization timelines, intellectual property expansions, and collaborative research initiatives.

technicals

An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. Bookmark this page to monitor Know Labs’ advancements in replacing invasive blood tests with electromagnetic-based solutions, including their flagship non-invasive glucose monitor currently under regulatory review. Know Labs, which recently moved from NYSE American (KNW) to OTC Pink Markets (KNWN), is known for its work in radio frequency dielectric spectroscopy (RFDS) technology.